BioSpace News Archive

Salarius Pharmaceuticals, Inc. today announced that the Company will host a conference call and live audio webcast on Thursday, May 12, 2022, at 5:00 p.m. ET, to discuss its corporate and financial results for the three months ended March 31, 2022.

Intellia Therapeutics, Inc. today reported operational highlights and financial results for the first quarter ended March 31, 2022.

KemPharm, Inc. today announced the submission of an Investigational New Drug (IND) application seeking authorization from the U.S. Food and Drug Administration.

Biogen Inc. and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment of gait deficits in multiple sclerosis.

Radius Health, Inc., reported its financial results for the first quarter ended March 31, 2022.

BridgeBio Pharma, Inc. today reported its financial results for the first quarter ended March 31, 2022 and provided an update on the Company’s operations.

Enveric Biosciences , Inc. today announced that it will host a virtual fireside chat with its Chief Medical Officer, Dr. Bob Dagher, on Tuesday, May 17, 2022.

HCW Biologics Inc. is presenting two groups of novel immunotherapeutics created with its proprietary and powerful Tissue factOr-Based fusIon (TOBI™) discovery platform at the 105th Annual Meeting of the American Association of Immunologists (AAI), or Immunology 2022.

Marinus Pharmaceuticals, Inc. today announced that it has resumed screening and recruitment for the Phase 3 RAISE (Randomized Therapy in Status Epilepticus) trial in refractory status epilepticus (RSE).

Stryker announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee.